Zobrazeno 1 - 10
of 10
pro vyhledávání: '"David DeLurgio"'
Autor:
Karan Wats, Andy Kiser, Kevin Makati, Nitesh Sood, David DeLurgio, Yisachar Greenberg, Felix Yang
Publikováno v:
Arrhythmia & Electrophysiology Review, Vol 9, Iss 2, Pp 88-96 (2020)
Externí odkaz:
https://doaj.org/article/062ae854113345f29471397d0e8d1a8c
Autor:
Siva Kumar, C.M. Nagesh, Manmohan Singh, Anbu Pandian, David Delurgio, Bobby Khan, Robin Chaudhary, Prashant Gupta
Publikováno v:
Indian Pacing and Electrophysiology Journal, Vol 20, Iss 2, Pp 54-59 (2020)
Background: The SanketLife is a low cost, portable, pocket sized 12 lead ECG mechanised by SanketLife app running on compatible iOS and Android phones that connect wirelessly via Bluetooth technology to the device. Objective: The current study was co
Externí odkaz:
https://doaj.org/article/f46a3fa1b2864130bbb5c9e87aefb5e5
Publikováno v:
Cardiovascular Revascularization Medicine. 40:225-230
Autor:
Shephal K. Doshi, Saibal Kar, Ashish Sadhu, Rodney Horton, Jose Osorio, Christopher Ellis, James Stone, Manish Shah, Srinivas R. Dukkipati, Stuart Adler, Devi G. Nair, Jamie Kim, Oussama Wazni, Matthew J. Price, David R. Holmes, Robert Shipley, Thomas Christen, Dominic J. Allocco, Vivek Y. Reddy, Maurice Buchbinder, Larry Chinitz, David Delurgio, Amish Desai, Health Center, Shephal Doshi, Srinivas R. Dukkipatti, Douglas Gibson, David Holmes, Kenneth Huber, Farhat Khairallah, Jayanthi Koneru, Paul Mahoney, Moussa Mansour, George Mark, Devi Nair, William O’Neill, William Nicholson, James Reiss, Walid Saliba, Michael Shehata, Vijendra Swarup
Publikováno v:
Journal of the American Heart Association. 12
Background The PINNACLE FLX (Protection Against Embolism for Non‐valvular AF [Atrial Fibrillation] Patients: Investigational Device Evaluation of the Watchman FLX LAA [Left Atrial Appendage] Closure Technology) trial evaluated the safety and effica
Autor:
David DeLurgio
Catheter ablation for treatment of symptomatic non-paroxysmal atrial fibrillation remains challenging. Clinical failure and need for continued medical therapy or repeat ablation is common, especially in more advanced forms of atrial fibrillation. Hyb
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::9ec701c15ebb4987be28d0483703a5ca
https://doi.org/10.22541/au.167081585.52557632/v1
https://doi.org/10.22541/au.167081585.52557632/v1
Autor:
Hugh Calkins, David DeLurgio, Lee H. Schwamm, Darryl Wells, Kurt Stromberg, Andrew Wickliffe, Joseph Souza, Atul Verma, Daryl Gress, John D. Hummel, Lauren Hemingway, Robert B. Hokanson, Lucas V.A. Boersma, Robert Hoyt
Publikováno v:
Journal of Cardiovascular Electrophysiology. 31:1289-1297
Introduction The VICTORY AF Study was designed to evaluate the risk of the procedure and/or device-related strokes in patients with PersAF on warfarin undergoing ablation with a phased radiofrequency (RF) system. Methods The VICTORY AF trial was a pr
Autor:
suvash shrestha, Kristen Plasseraud, Kevin Makati, Nitesh Sood, David DeLurgio, Yisachar Greenberg, Felix Yang
Publikováno v:
Circulation. 144
Introduction: Recent randomized clinical trial data demonstrated safety and effectiveness of hybrid epicardial-endocardial (convergent) ablation for persistent and longstanding persistent atrial fibrillation (PersAF/LSPAF). The objective of this stud
Publikováno v:
Journal of the American College of Cardiology. 75:441
Autor:
Mikhael F, El-Chami, Mathew, Levy, Heval M, Kelli, Mary, Casey, Michael H, Hoskins, Abhinav, Goyal, Jonathan J, Langberg, Anshul, Patel, David, Delurgio, Michael S, Lloyd, Angel R, Leon, Faisal M, Merchant
Publikováno v:
Journal of cardiovascular electrophysiology. 26(8)
Although the subcutaneous ICD (S-ICD®) is an attractive alternative in patients with end-stage renal disease (ESRD), data on S-ICD outcomes in dialysis patients are lacking.Patients with cardiomyopathy undergoing S-ICD implantation in our center wer
Autor:
Jonathan J. Langberg, David DeLurgio, Fernando Mera, Charn Sathavorn, Andreas Bollmann, Paul F. Walter, Alexandra Marx
Publikováno v:
Pacing and clinical electrophysiology : PACE. 22(1 Pt 2)
BACKGROUND The miniaturization of implantable cardioverter defibrillators (ICDs) has made pectoral implantation possible. However, postoperative pain following the procedure has not been systematically studied. The aim of the current study was to pro